Ding M, Tarwater P, Rodriguez M, Chatterjee R, Ratner D, Yamamura Y, Roy P, Mellors J, Neogi D, Chen Y, Gupta P. Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India. J Acquir Immune Defic Syndr. Feb 2009;50(2):119-125. Impact Factor (as of 2008): 4.412.
 

Cosme RS, Yamamura Y, Tang Q. Roles of Polypyrimidine Tract Binding Proteins on Major Immediate Early Gene Expression and Viral Replication of Human Cytomegalovirus. J Virol. 2009 Jan 14. [Epub ahead of print]. Impact Factor (as of 2007): 5.332.
 

Rodríguez N, Vargas Vidot J, Panelli J, Colón H, Ritchie B, Yamamura Y. GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles. Drug Alcohol Depend. May 8, 2008 [Epub ahead of print]. Impact Factor (as of 2007): 3.213.
 

Vélez R, Sánchez M del C, Lopez P, Yamamura Y. A new procedure for the quantitative assessment of p-glycoprotein efflux pump associated with human T lymphocytes. Ethn Dis. 2008;18(2 Suppl 2):S2-75-80. Impact Factor (as of 2008): 0.857.
 

Sánchez M del C, López P, Vélez R, Yamamura Y. P-glycoprotein expression in HTLV-III cells after treatment with HIV-1 protease inhibitors. Ethn Dis. 2008;18(2 Suppl 2):S2-60-46. Impact Factor (as of 2008): 0.857.